Brian Mueller - 23 Nov 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
23 Nov 2022
Net transactions value
-$293,757
Form type
4
Filing time
28 Nov 2022, 20:42:03 UTC
Previous filing
09 Aug 2022
Next filing
06 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale $88,814 -934 -3% $95.09 29,792 23 Nov 2022 Direct F1
transaction BMRN Common Stock Sale $94,028 -945 -3.2% $99.50 28,847 23 Nov 2022 Direct F1
transaction BMRN Common Stock Options Exercise $237,335 +3,500 +12% $67.81 32,347 23 Nov 2022 Direct F1
transaction BMRN Common Stock Sale $348,250 -3,500 -11% $99.50 28,847 23 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -3,500 -48% $0.000000 3,761 23 Nov 2022 Common Stock 3,500 $67.81 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.